How I made this: brain injury innovators collaborate in Macquarie Park
What happens when two innovators working on managing injuries sit side-by-side in a start up incubator? Meet Ed from GLIA Diagnostics and Shane and Daniel from Invicta Prospects Group as they share their collaboration story, and why innovating in Macquarie Park has been great for them both.
Invicta Prospects Group is an Australian veteran-owned business, specialising in the development and support of software solutions to better manage workforce training - particularly in blast and trauma environments. GLIA Diagnostics are developing biomarkers to create an on the spot concussion diagnostic tool, and reduce brain injuries.
When the two sat down together at Macquarie University Incubator it turned out to to be a serendipitous moment for both parties, as Ed from GLIA Diagnostics explains:
“It’s given us an opportunity to really work together on a daily basis, to really innovate as two businesses collaborating in the defence space” said Daniel.
Shane and Daniel, formerly of the Australian Defence Force, designed their “Buddy Suite” software to help manage workforce capability, increase safety and save lives. It provides organisations with insights on data captured from participants, which can be managed in a highly configurable and customisable way.
GLIA Diagnostic’s aim is to increase understanding of brain related injury - with particular emphasis on concussion - and to ultimately discover a biomarker(s) that will help in creating a new diagnostic tool.
Since this How I Made This case study was filmed, both teams have continued to grow their businesses. Ed will speak at the Australian Tactical Medicine Conference later this month, and Shane and Daniel were recently awarded a Defence Innovation Hub contract by the Federal Government, as part of a $23m AUD investment in the field.
Surrounded by research and commerce, and with access to cutting-edge facilities, collaborating in Macquarie Park has been a fruitful experience, as Ed explains:
“You’re in the greater Macquarie Park area, and there’s big tech here there’s pharmaceutical companies so it opens up that opportunity to collaborate as well,” notes Ed.
